Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Ventas鈥� filings can feel like sorting through hundreds of pages on rent escalators, triple-net lease covenants, and senior-housing occupancy rates. If you鈥檝e ever asked, 鈥淲here鈥檚 the dividend guidance hidden in Ventas鈥� annual report 10-K?鈥� or hunted for Ventas insider trading Form 4 transactions, you know the challenge.
Stock Titan solves it. Our platform ingests every Ventas quarterly earnings report 10-Q filing, 8-K, and proxy in real time, then delivers plain-English, AI-powered summaries. Need Ventas Form 4 insider transactions real-time? Get instant alerts. Trying to compare deferred rent trends quarter over quarter? Our AI highlights the numbers and adds context so you鈥檙e understanding Ventas SEC documents with AI instead of decoding footnotes.
You鈥檒l find more than a list of forms. We connect each document to what matters for a healthcare REIT: the 10-K section that forecasts SHOP margins, the 8-K paragraph announcing operator restructurings (Ventas 8-K material events explained), or the Ventas proxy statement executive compensation table that details incentive targets. Whether you鈥檙e scanning a Ventas annual report 10-K simplified for dividend coverage or running a quick Ventas earnings report filing analysis, the insights are ready in minutes鈥攏o spreadsheet gymnastics required. Monitor Ventas executive stock transactions Form 4, track payout ratios, and see AI-generated red-flag alerts across ALL filing types the moment they hit EDGAR.
Form 4 filing overview: On 07/01/2025, Ventas, Inc. (VTR) director Sumit Roy acquired 497.057 common share units under the company鈥檚 Non-Employee Directors鈥� Cash Compensation Deferral Plan. The units were credited in lieu of cash director fees at the market closing price of $62.87 per share, implying a transaction value of roughly $31,000.
Following the grant, Roy鈥檚 direct beneficial ownership rises to 20,642.266 shares. No shares were sold, and there were no derivative security transactions reported. Because the transaction is part of a standing fee-deferral election, it appears routine rather than opportunistic trading, yet it still incrementally aligns the director鈥檚 interests with those of shareholders.
Overall, the filing signals a small, non-dilutive insider purchase that marginally increases insider ownership but is unlikely to have a material impact on Ventas鈥� valuation or trading dynamics given the company鈥檚 large market capitalization.
Form 4 filing overview: On 07/01/2025, Ventas, Inc. (VTR) director Sumit Roy acquired 497.057 common share units under the company鈥檚 Non-Employee Directors鈥� Cash Compensation Deferral Plan. The units were credited in lieu of cash director fees at the market closing price of $62.87 per share, implying a transaction value of roughly $31,000.
Following the grant, Roy鈥檚 direct beneficial ownership rises to 20,642.266 shares. No shares were sold, and there were no derivative security transactions reported. Because the transaction is part of a standing fee-deferral election, it appears routine rather than opportunistic trading, yet it still incrementally aligns the director鈥檚 interests with those of shareholders.
Overall, the filing signals a small, non-dilutive insider purchase that marginally increases insider ownership but is unlikely to have a material impact on Ventas鈥� valuation or trading dynamics given the company鈥檚 large market capitalization.
ON24, Inc. (ONTF) 鈥� Form 4 insider transaction
President & CEO Sharan Sharat reported the sale of 61,467 common shares on 30 Jun 2025 at a weighted-average price of $5.4665. The disposition was executed under a pre-arranged Rule 10b5-1 trading plan (adopted 12 Dec 2024) and was specifically designated to satisfy tax-withholding obligations arising from the vesting of restricted stock units (RSUs). After the sale, Sharat continues to hold 3,550,917 shares directly.
The transaction represents roughly 1.7 % of the reporting person鈥檚 stated ownership and does not appear to reflect a discretionary change in economic exposure. No derivative security transactions were reported.
Because the shares were sold to cover taxes and the executive retains a substantial stake, the filing is generally interpreted as administrative/neutral rather than a signal of deteriorating insider sentiment. Investors may still monitor additional sales or modifications to the existing 10b5-1 plan for trend analysis.
ON24, Inc. (ONTF) 鈥� Form 4 insider transaction
President & CEO Sharan Sharat reported the sale of 61,467 common shares on 30 Jun 2025 at a weighted-average price of $5.4665. The disposition was executed under a pre-arranged Rule 10b5-1 trading plan (adopted 12 Dec 2024) and was specifically designated to satisfy tax-withholding obligations arising from the vesting of restricted stock units (RSUs). After the sale, Sharat continues to hold 3,550,917 shares directly.
The transaction represents roughly 1.7 % of the reporting person鈥檚 stated ownership and does not appear to reflect a discretionary change in economic exposure. No derivative security transactions were reported.
Because the shares were sold to cover taxes and the executive retains a substantial stake, the filing is generally interpreted as administrative/neutral rather than a signal of deteriorating insider sentiment. Investors may still monitor additional sales or modifications to the existing 10b5-1 plan for trend analysis.
FAQ
What is the current stock price of Ventas (VTR)?
What is the market cap of Ventas (VTR)?
What is the primary focus of Ventas, Inc.?
How does Ventas generate its revenue?
What types of properties are included in Ventas' portfolio?
In which regions does Ventas operate?
How is Ventas positioned within the healthcare real estate market?
What factors contribute to the company鈥檚 financial stability?
How does Ventas ensure operational excellence?
